JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 7, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/50/47709    most recent
M107878200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tong, X.
Right arrow Articles by Koeffler, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tong, X.
Right arrow Articles by Koeffler, P. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 11, 2001
J. Biol. Chem, 10.1074/jbc.M107878200
Submitted on August 16, 2001
Revised on October 9, 2001
Accepted on October 10, 2001

Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer

Xiangjun Tong, Dong Xie, James O'Kelly, Carl W. Miller, Carsten Muller-Tidow, and Phillip H. Koeffler

Department of Hem/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048

Corresponding Author: xiangjuntong{at}hotmail.com

Cyr61 (Cysteine-rich protein 61) is a member of a family of growth factor-inducible immediate-early genes. It regulates cell adhesion, migration, proliferation and differentiation, and is involved in tumor growth. In our experiments, the role of Cyr61 in non-small cell lung cancer (NSCLC) was examined. Expression of Cyr61 mRNA was markedly decreased in four of 5 human lung tumor samples compared to their normal matched lung samples. NSCLC cell lines NCI-H520 and H460, which have no endogenous Cyr61, formed 60-90% fewer colonies after transfected with a Cyr61 cDNA expression vector than cells transfected with the same amount of empty vector. After stable transfection of a Cyr61 cDNA expression vector, proliferation of both H520-Cyr61 and H460-Cyr61 sublines decreased remarkably compared to the cells stably transfected with empty vector. The addition of antibody against Cyr61 partially rescued the growth suppression of both H520-Cyr61 and H460-Cyr61 cells. Cell cycle analysis revealed that both H520-Cyr61 and H460-Cyr61 cells developed G1 arrest, prominently up-regulated expression of p53 and p21WAF1 and had decreased activity of cyclin-dependent kinase 2 (CDK2). The increase of pocket protein pRB2/p130 was also detected in these cells. Notably, both of the Cyr61 stably transfected lung cancer cell lines developed smaller tumors than those formed by the wild-type cells in nude mice. Taken together, we conclude that Cyr61 may play a role as a tumor suppressor in NSCLC.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Interv.Home page
C. T. Walsh, D. Stupack, and J. H. Brown
G Protein-Coupled Receptors Go Extracellular: RhoA Integrates the Integrins
Mol. Interv., August 1, 2008; 8(4): 165 - 173.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Liu, R. Yang, B. Tinner, A. Choudhry, N. Schutze, and B. Chaqour
Cysteine-Rich Protein 61 and Connective Tissue Growth Factor Induce Deadhesion and Anoikis of Retinal Pericytes
Endocrinology, April 1, 2008; 149(4): 1666 - 1677.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B.-R. Lin, C.-C. Chang, L.-R. Chen, M.-H. Wu, M.-Y. Wang, I-H. Kuo, C.-Y. Chu, K.-J. Chang, P.-H. Lee, W.-J. Chen, et al.
Cysteine-Rich 61 (CCN1) Enhances Chemotactic Migration, Transendothelial Cell Migration, and Intravasation by Concomitantly Up-Regulating Chemokine Receptor 1 and 2
Mol. Cancer Res., November 1, 2007; 5(11): 1111 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Kikuchi, H. Tsuda, Y. Kanai, T. Kasamatsu, K. Sengoku, S. Hirohashi, J. Inazawa, and I. Imoto
Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer
Cancer Res., August 1, 2007; 67(15): 7095 - 7105.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. D. MacLaughlan, W. A. Palomino, B. Mo, T. D. Lewis, R. A. Lininger, and B. A. Lessey
Endometrial Expression of Cyr61: A Marker of Estrogenic Activity in Normal and Abnormal Endometrium
Obstet. Gynecol., July 1, 2007; 110(1): 146 - 154.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W. Chien, D. Yin, D. Gui, A. Mori, J. M. Frank, J. Said, D. Kusuanco, A. Marchevsky, R. McKenna, and H. P. Koeffler
Suppression of Cell Proliferation and Signaling Transduction by Connective Tissue Growth Factor in Non-Small Cell Lung Cancer Cells
Mol. Cancer Res., August 1, 2006; 4(8): 591 - 598.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Gery, D. Xie, D. Yin, H. Gabra, C. Miller, H. Wang, D. Scott, W. S. Yi, M. L. Popoviciu, J. W. Said, et al.
Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells
Clin. Cancer Res., October 15, 2005; 11(20): 7243 - 7254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Jin, H. P. Kim, E. Ifedigbo, L. F. Lau, and A. M. K. Choi
Cyr61 Protects against Hyperoxia-Induced Cell Death via Akt Pathway in Pulmonary Epithelial Cells
Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M.-T. Lin, C.-Y. Zuon, C.-C. Chang, S.-T. Chen, C.-P. Chen, B.-R. Lin, M.-Y. Wang, Y.-M. Jeng, K.-J. Chang, P.-H. Lee, et al.
Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-{kappa}B/Cyclooxygenase-2 Signaling Pathway
Clin. Cancer Res., August 15, 2005; 11(16): 5809 - 5820.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. R. Grotendorst and M. R. Duncan
Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation
FASEB J, May 1, 2005; 19(7): 729 - 738.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Takai, N. Kawamata, C. S. Walsh, S. Gery, J. C. Desmond, S. Whittaker, J. W. Said, L. M. Popoviciu, P. A. Jones, I. Miyakawa, et al.
Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer
Mol. Cancer Res., May 1, 2005; 3(5): 261 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chien, T. Kumagai, C. W. Miller, J. C. Desmond, J. M. Frank, J. W. Said, and H. P. Koeffler
Cyr61 Suppresses Growth of Human Endometrial Cancer Cells
J. Biol. Chem., December 17, 2004; 279(51): 53087 - 53096.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S.-M. Kim, J.-H. Park, S.-K. Chung, J.-Y. Kim, H.-Y. Hwang, K.-C. Chung, I. Jo, S.-I. Park, and J.-H. Nam
Coxsackievirus B3 Infection Induces cyr61 Activation via JNK To Mediate Cell Death
J. Virol., December 15, 2004; 78(24): 13479 - 13488.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
W. G Jiang, G. Watkins, O. Fodstad, A. Douglas-Jones, K. Mokbel, and R. E Mansel
Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer
Endocr. Relat. Cancer, December 1, 2004; 11(4): 781 - 791.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C.-C. Chang, J.-Y. Shih, Y.-M. Jeng, J.-L. Su, B.-Z. Lin, S.-T. Chen, Y.-P. Chau, P.-C. Yang, and M.-L. Kuo
Connective Tissue Growth Factor and Its Role in Lung Adenocarcinoma Invasion and Metastasis
J Natl Cancer Inst, March 3, 2004; 96(5): 364 - 375.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. R. van Ginkel, R. L. Gee, R. L. Shearer, L. Subramanian, T. M. Walker, D. M. Albert, L. F. Meisner, B. C. Varnum, and A. S. Polans
Expression of the Receptor Tyrosine Kinase Axl Promotes Ocular Melanoma Cell Survival
Cancer Res., January 1, 2004; 64(1): 128 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A E Bonner, W J Lemon, and M You
Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis
J. Med. Genet., June 1, 2003; 40(6): 408 - 417.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. H. Kim, Y. K. Min, J.-H. Baik, L. F. Lau, B. Chaqour, and K. C. Chung
Expression of Angiogenic Factor Cyr61 during Neuronal Cell Death via the Activation of c-Jun N-terminal Kinase and Serum Response Factor
J. Biol. Chem., April 11, 2003; 278(16): 13847 - 13854.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. L. Soon, T.-A. Yie, A. Shvarts, A. J. Levine, F. Su, and K.-M. Tchou-Wong
Overexpression of WISP-1 Down-regulated Motility and Invasion of Lung Cancer Cells through Inhibition of Rac Activation
J. Biol. Chem., March 21, 2003; 278(13): 11465 - 11470.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.